Grail Stock Popped Today: What's Driving the Move Now
When a biotech stock jumps after a conference, investors want to know if it’s sustainable. This article breaks down w...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
158 articlesBionano (BNGO) 2026 Earnings Outlook for Investors
Investors are watching Bionano Genomics as the company enters 2026 with evolving demand for optical genome mapping. T...
Treace Medical (TMCI) 2026 Investment Outlook Guide
As Treace Medical eyes 2026, investors weigh adoption of Lapiplasty, payer dynamics, and global expansion. This guide...
This $5.5 Million Exit: Lessons From Wave Life Sciences and a Tough Quarter
A high-stakes exit valued at about $5.5 million and a difficult first quarter have investors re-evaluating risk in bi...
Crispr Therapeutics Editas Medicine: Better Buy in 2026?
Two top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
HeartFlow Stock After Institutional Moves: Buy or Not?
When an institutional investor takes a large position in a biotech stock, it can signal potential credibility or risk...
Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Co-Diagnostics (CODX) 2025 Earnings: Catalysts & Risks
Investors are keeping a close eye on Co-Diagnostics as 2025 earnings unfold. This guide breaks down what to look for ...
Boston Scientific Betting $1.5 Billion: Market Bets and Implications
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Investment Firm Closes Biotech Stake, SEC Filing
A big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Related Topics
#Investing (126)
#Stock Analysis (39)
#Earnings Analysis (28)
#Insider Trading (22)
#Stock Market (16)
#Stock Market News (16)
#Earnings (14)
#Portfolio Strategy (12)
#Portfolio Management (11)
#Investing Strategy (9)
#SEC Filings (7)
#risk-management (6)
#Hedge Funds (6)
#CRISPR (6)
#Pharmaceuticals (5)